Ischemic heart disease is the leading cause of mortality worldwide. In this context, myocar- dial viability is defined as the amount of myocardium that, despite contractile dysfunction, maintains metabolic and electrical function, having the potential for functional enhancement upon revascular- ization. Recent advances have improved methods to detect myocardial viability. The current paper summarizes the pathophysiological basis of the current methods used to detect myocardial viability in light of the advancements in the development of new radiotracers for cardiac imaging.

Tracers for Cardiac Imaging: Targeting the Future of Viable Myocardium / Nappi, Carmela; Panico, Mariarosaria; Falzarano, Maria; Vallone, Carlo; Ponsiglione, Andrea; Cutillo, Paolo; Zampella, Emilia; Petretta, Mario; Cuocolo, Alberto. - In: PHARMACEUTICS. - ISSN 1999-4923. - 15:5(2023), p. 1532. [10.3390/pharmaceutics15051532]

Tracers for Cardiac Imaging: Targeting the Future of Viable Myocardium

Nappi, Carmela
;
Falzarano, Maria;Vallone, Carlo;Ponsiglione, Andrea;Cutillo, Paolo;Zampella, Emilia;Cuocolo, Alberto
2023

Abstract

Ischemic heart disease is the leading cause of mortality worldwide. In this context, myocar- dial viability is defined as the amount of myocardium that, despite contractile dysfunction, maintains metabolic and electrical function, having the potential for functional enhancement upon revascular- ization. Recent advances have improved methods to detect myocardial viability. The current paper summarizes the pathophysiological basis of the current methods used to detect myocardial viability in light of the advancements in the development of new radiotracers for cardiac imaging.
2023
Tracers for Cardiac Imaging: Targeting the Future of Viable Myocardium / Nappi, Carmela; Panico, Mariarosaria; Falzarano, Maria; Vallone, Carlo; Ponsiglione, Andrea; Cutillo, Paolo; Zampella, Emilia; Petretta, Mario; Cuocolo, Alberto. - In: PHARMACEUTICS. - ISSN 1999-4923. - 15:5(2023), p. 1532. [10.3390/pharmaceutics15051532]
File in questo prodotto:
File Dimensione Formato  
pharmaceutics-15-01532.pdf

accesso aperto

Descrizione: Articolo in rivista
Tipologia: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 5.13 MB
Formato Adobe PDF
5.13 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/920914
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact